IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q2 2023 Holdings

Filed 2023-08-11 | 26 holdings | $329.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-08-22) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pliant Therapeutics Inc(PLRX)COM729139105$56.5M3,117,01717.1%
Acelyrin IncCOM00445A100$55.7M2,663,80616.9%
Vectivbio Hldg AGORD SHSH9060V101$46.9M2,782,75614.2%
Cullinan Oncology Inc(CGEM)COM230031106$36.7M3,414,18911.1%
Repare Therapeutics Inc(RPTX)COM760273102$31.7M2,998,7349.6%
Keros Therapeutics Inc(KROS)COM492327101$16.2M402,1184.9%
Ikena Oncology IncCOM45175G108$13.9M2,122,0404.2%
Compass Therapeutics Inc(CMPX)COM20454B104$9.0M2,829,7122.7%
Larimar Therapeutics Inc(LRMR)COM517125100$8.7M3,414,4682.6%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$8.6M852,0072.6%
Inozyme Pharma IncCOM45790W108$6.7M1,195,0272.0%
Omega Therapeutics IncCOMMON STOCK68217N105$5.9M1,055,8821.8%
Disc Medicine Inc(IRON)COM254604101$5.6M125,1391.7%
Direxion SHS ETF TR(LABDUSD)DAILY S&P BIOTEC25460G716$4.7M325,0001.4%
Orchard Therapeutics PLCASPON ADS NEW68570P200$3.9M755,7381.2%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$3.9M85,0001.2%
Black Diamond Therapeutics I(BDTX)COM09203E105$3.8M750,0001.1%
Rallybio CorpCOM75120L100$3.1M542,7740.9%
Ovid Therapeutics Inc(OVID)COM690469101$2.8M864,8220.9%
Syros Pharmaceuticals Inc(SYRS)COM NEW87184Q206$2.4M767,4450.7%
Precision Biosciences IncCOM74019P108$843.5K1,603,5570.3%
Hookipa Pharma IncCOM43906K100$694.1K788,7400.2%
Graphite BIO Inc(GRPH)COM38870X104$600.4K230,9380.2%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$458.0K200,0000.1%
Pliant Therapeutics Inc(PLRX)CallCOM729139105$161.8K130,3000.0%
Freeline Therapeutics HldgsASPONSORED ADS35655L206$55.9K21,6660.0%